Fingerprint
Dive into the research topics where Melissa Heffler is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
-
Down-regulation of ALDH1A3, CD44 or MDR1 sensitizes resistant cancer cells to FAK autophosphorylation inhibitor Y15
Golubovskaya, V., O’Brien, S., Ho, B., Heffler, M., Conroy, J., Hu, Q., Wang, D., Liu, S. & Cance, W. G., Sep 18 2015, In: Journal of Cancer Research and Clinical Oncology. 141, 9, p. 1613-1631 19 p.Research output: Contribution to journal › Article › peer-review
20 Scopus citations -
FAK and HAS inhibition synergistically decrease colon cancer cell viability and affect expression of critical genes
Heffler, M., Golubovskaya, V. M., Conroy, J., Liu, S., Wang, D., Cance, W. G. & Dunn, K. B., 2013, In: Anti-Cancer Agents in Medicinal Chemistry. 13, 4, p. 584-594 11 p.Research output: Contribution to journal › Article › peer-review
Open Access21 Scopus citations -
Focal adhesion kinase autophosphorylation inhibition decreases colon cancer cell growth and enhances the efficacy of chemotherapy
Heffler, M., Golubovskaya, V. M., Dunn, K. M. B. & Cance, W., Aug 2013, In: Cancer Biology and Therapy. 14, 8, p. 761-772 12 p.Research output: Contribution to journal › Article › peer-review
Open Access44 Scopus citations -
Inhibition of hyaluronan synthase-3 decreases subcutaneous colon cancer growth by increasing apoptosis
Teng, B. P., Heffler, M. D., Lai, E. C., Zhao, Y. L., LeVea, C. M., Golubovskaya, V. M. & Bullarddunn, K. M., Sep 2011, In: Anti-Cancer Agents in Medicinal Chemistry. 11, 7, p. 620-628 9 p.Research output: Contribution to journal › Article › peer-review
26 Scopus citations -
Evolving Therapies and FAK Inhibitors for the Treatment of Cancer
Dunn, K. B., Heffler, M. & Golubovskaya, V. M., 2010, In: Anti-Cancer Agents in Medicinal Chemistry. 10, 10, p. 722-734 13 p.Research output: Contribution to journal › Review article › peer-review
Open Access48 Scopus citations